Evidence map›Paper›PMID 30371233›Full record

ArticleJournal of the American Heart Association2018

Elimination of Purkinje Fibers by Electroporation Reduces Ventricular Fibrillation Vulnerability.

Christopher Livia, Alan Sugrue, Tyra Witt, Murray D Polkinghorne, Elad Maor, Suraj Kapa, Helge I Lehmann, Christopher V DeSimone, Atta Behfar, Samuel J Asirvatham and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 68 citations in OpenAlex.

  1. Irreversible electroporation for catheter-based cardiac ablation: a systematic review of the preclinical experience.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2019
    Pooled it
  2. Specific effects of Pulsed Field Ablation on the cardiac tissue, the nervous system and the conduction system in experimental and clinical studies.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026
    Review
  3. Nanosecond pulse electric field treatment initiates mitochondrial apoptosis pathway by inducing mitochondrial morphological changes in myocardial cells.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2026
    Article
  4. Review
  5. Mapping and ablation of ventricular fibrillation substrate.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2026
    Review
  6. Novel insights into the substrate involved in maintenance of ventricular fibrillation: results from continuous multipolar mapping in a canine model.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2026
    Article
  7. Review
  8. Pulsed field ablation of ventricular arrhythmias arising from intracavitary structures: insights from a clinical case series.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2025
    Article
  9. Empirical disconnection of left posterior fascicle: a new paradigm in catheter ablation of ventricular fibrillation.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2025
    Article
  10. Observational
  11. Review
  12. Review
  13. Review
  14. Contemporary Trends in Pulsed Field Ablation for Cardiac Arrhythmias.Journal of cardiovascular development and disease · 2024
    Review
  15. Pulsed Field Ablation: A Comprehensive Update.Journal of clinical medicine · 2024
    Review
  16. Impact of Pulsed Electric Field Ablation on His Bundle Conduction: A Preclinical Canine Study.Medical science monitor : international medical journal of experimental and clinical research · 2024
    Article
  17. Article
  18. Review
  19. Differential effect of high-frequency electroporation on myocardium vs. non-myocardial tissues.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Christopher Livia1 Department of Cardiovascular Medicine and Department of Molecular Pharmacology and Experimental Therapeutics Center for Regenerative Medicine Mayo Clinic Rochester MN.
Alan Sugrue2 Division of Heart Rhythm Services Department of Cardiovascular Diseases Mayo Clinic Rochester MN.
Tyra Witt1 Department of Cardiovascular Medicine and Department of Molecular Pharmacology and Experimental Therapeutics Center for Regenerative Medicine Mayo Clinic Rochester MN.
Murray D Polkinghorne2 Division of Heart Rhythm Services Department of Cardiovascular Diseases Mayo Clinic Rochester MN.
Elad Maor4 Leviev Heart Center, Sheba Medical Center Sackler School of Medicine Tel Aviv University Tel Aviv Israel.
Suraj Kapa2 Division of Heart Rhythm Services Department of Cardiovascular Diseases Mayo Clinic Rochester MN.
Helge I Lehmann2 Division of Heart Rhythm Services Department of Cardiovascular Diseases Mayo Clinic Rochester MN.
Christopher V DeSimone2 Division of Heart Rhythm Services Department of Cardiovascular Diseases Mayo Clinic Rochester MN.
Atta Behfar1 Department of Cardiovascular Medicine and Department of Molecular Pharmacology and Experimental Therapeutics Center for Regenerative Medicine Mayo Clinic Rochester MN.
Samuel J Asirvatham2 Division of Heart Rhythm Services Department of Cardiovascular Diseases Mayo Clinic Rochester MN.
Christopher J McLeod2 Division of Heart Rhythm Services Department of Cardiovascular Diseases Mayo Clinic Rochester MN.
Mayo Clinic in Arizona · USMayo Clinic · USSheba Medical Center · IL

Funding

Medical Scientist Traning Program at Mayo ClinicT32GM065841 · NIGMS · MAYO CLINIC ROCHESTER · PI KAUFMANN, SCOTT H, SCHIMMENTI, LISA A · 2003 to 2022
$5.8M
Predoctoral Training Program in Molecular PharmacologyT32GM072474 · NIGMS · MAYO CLINIC ROCHESTER · PI KARNITZ, LARRY M · 2005 to 2020
$2.4M
NIGMS NIH HHS T32 GM065841NIGMS NIH HHS T32 GM072474
6 · The paper itself

Abstract

Background The Purkinje network appears to play a pivotal role in the triggering as well as maintenance of ventricular fibrillation. Irreversible electroporation ( IRE ) using direct current has shown promise as a nonthermal ablation modality in the heart, but its ability to target and ablate the Purkinje tissue is undefined. Our aim was to investigate the potential for selective ablation of Purkinje/fascicular fibers using IRE . Methods and Results In an ex vivo Langendorff model of canine heart (n=8), direct current was delivered in a unipolar manner at various dosages from 750 to 2500 V, in 10 pulses with a 90-μs duration at a frequency of 1 Hz. The window of ventricular fibrillation vulnerability was assessed before and after delivery of electroporation energy using a shock on T-wave method. IRE consistently eradicated all Purkinje potentials at voltages between 750 and 2500 V (minimum field strength of 250-833 V/cm). The ventricular electrogram amplitude was only minimally reduced by ablation: 0.6±2.3 mV ( P=0.03). In 4 hearts after IRE delivery, ventricular fibrillation could not be reinduced. At baseline, the lower limit of vulnerability to ventricular fibrillation was 1.8±0.4 J, and the upper limit of vulnerability was 19.5±3.0 J. The window of vulnerability was 17.8±2.9 J. Delivery of electroporation energy significantly reduced the window of vulnerability to 5.7±2.9 J ( P=0.0003), with a postablation lower limit of vulnerability=7.3±2.63 J, and the upper limit of vulnerability=18.8±5.2 J. Conclusions Our study highlights that Purkinje tissue can be ablated with IRE without any evidence of underlying myocardial damage.

Indexed as

Ablation TechniquesAnimalsDisease SusceptibilityDogsElectrophysiologic Techniques, CardiacElectroporationIsolated Heart PreparationPurkinje FibersVentricular Fibrillationablationdirect current ablationirreversible electroporationPurkinje fibersventricular fibrillationwindow of vulnerability

Identifiers

PMID30371233
PMCPMC6201470
OpenAlexW2887110367

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.